Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | jun protein | 0.0171 | 0.2535 | 0.2535 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0047 | 0.0005 | 0.002 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.2502 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0548 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.2188 |
Echinococcus multilocularis | jun protein | 0.0171 | 0.2535 | 0.2535 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.5 |
Echinococcus multilocularis | Ankyrin | 0.0047 | 0.0005 | 0.0005 |
Schistosoma mansoni | hypothetical protein | 0.0139 | 0.1883 | 0.7525 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.306 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.306 | 0.306 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.2502 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0171 | 0.2535 | 0.2535 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.2188 |
Brugia malayi | hypothetical protein | 0.0134 | 0.1788 | 0.5842 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0548 | 0.0548 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.2439 | 0.7969 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0548 | 0.0548 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.306 | 0.306 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.306 | 1 |
Schistosoma mansoni | jun-related protein | 0.0139 | 0.1883 | 0.7525 |
Brugia malayi | bZIP transcription factor family protein | 0.0171 | 0.2535 | 0.8284 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0171 | 0.2535 | 0.2535 |
Echinococcus granulosus | Ankyrin | 0.0047 | 0.0005 | 0.0005 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0538 | 1 | 1 |
Onchocerca volvulus | 0.0134 | 0.1788 | 1 | |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.306 | 0.306 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0548 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.